Igor D. Bandeira MD PhD

Postdoctoral Research Fellow in the Department of Psychiatry and Behavioral Sciences at the Stanford University School of Medicine

Join to view full profile

3550 Market StSan Francisco, CA 94131

Dr. D. Bandeira is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. D. Bandeira's full profile Already have an account?

Education & Training

Stanford UniversityPost-Doctoral Fellowship, 2021
Federal University of Bahia Faculty of MedicineDoctor of Philosophy, 2019 - 2021
Federal University of Bahia Faculty of MedicineClass of 2018

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Awards, Honors, & Recognition

Alies Muskin Career Development Leadership Program Award Anxiety and Depression Association of America, 2025
New Investigator Award International Society for CNS Clinical Trials and Methodology, 2025
First Prize, Best Poster Award Winter Conference on Brain Research, 2025

Clinical Trials

Opiate Suicide Study in Patients With Major Depression Start of enrollment: 2020 Aug 01
COMPLETED
PHASE3
Personalized Therapeutic Neuromodulation for Anhedonic Depression Start of enrollment: 2022 May 31
COMPLETED
NA
Rapid Acting TMS for Suicide Ideation in Depression Start of enrollment: 2021 Nov 07
WITHDRAWN
NA

Publications & Presentations

PubMed

4 citations
Low-Dose Buprenorphine Following Ketamine Treatment for Suicidal Ideation in Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial.
Jason M Tucciarone, Igor D Bandeira, Christine Blasey, Ian H Kratter, Jarrod Ehrie
The American Journal of Psychiatry. 2026-06-01
Increased cortical thickness and decreased brain age among special operations veterans with blast TBI after a magnesium-ibogaine protocol.
Andrew D Geoly, John P Coetzee, Derrick Matthew Buchanan, Wiebke Struckmann, Bora Kim
Iscience. 2026-03-20
3 citations
Methodological considerations for interpreting ketamine-naltrexone trials in depression.
Igor D Bandeira, Luke A Jelen, Jason M Tucciarone, Boris D Heifets, Carolyn I Rodriguez
The International Journal of Neuropsychopharmacology. 2025-10-01